SynBiotic SE reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was EUR 8.65 million compared to EUR 5.45 million a year ago. Net loss was EUR 12.72 million compared to EUR 0.880389 million a year ago.

Basic loss per share from continuing operations was EUR 4.15 compared to EUR 0.56 a year ago. Diluted loss per share from continuing operations was EUR 4.15 compared to EUR 0.56 a year ago.